PMID- 29057642 OWN - NLM STAT- MEDLINE DCOM- 20180709 LR - 20181113 IS - 2005-6648 (Electronic) IS - 1226-3303 (Print) IS - 1226-3303 (Linking) VI - 32 IP - 6 DP - 2017 Nov TI - Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017. PG - 967-973 LID - 10.3904/kjim.2017.314 [doi] AB - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM. FAU - Lee, Byung-Wan AU - Lee BW AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. FAU - Kim, Jin Hwa AU - Kim JH AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea. FAU - Ko, Seung-Hyun AU - Ko SH AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. FAU - Hur, Kyu Yeon AU - Hur KY AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. FAU - Kim, Nan-Hee AU - Kim NH AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. FAU - Rhee, Sang Youl AU - Rhee SY AD - Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea. FAU - Kim, Hyun Jin AU - Kim HJ AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. FAU - Moon, Min Kyong AU - Moon MK AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea. FAU - Park, Seok-O AU - Park SO AD - Department of Internal Medicine, Gwangmyeong Sungae Hospital, Gwangmyeong, Korea. FAU - Choi, Kyung Mook AU - Choi KM AD - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. CN - Committee of Clinical Practice Guideline of Korean Diabetes Association LA - eng PT - Journal Article PT - Practice Guideline PT - Review DEP - 20171023 PL - Korea (South) TA - Korean J Intern Med JT - The Korean journal of internal medicine JID - 8712418 RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin) SB - IM MH - Diabetes Mellitus, Type 2/*drug therapy MH - Humans MH - Hypoglycemic Agents/*administration & dosage MH - Insulin/*administration & dosage PMC - PMC5668405 OTO - NOTNLM OT - Clinical practice guideline OT - Diabetes mellitus, type 2 OT - Hypoglycemic agents OT - Insulin OT - Korea COIS- No potential conflict of interest relevant to this article was reported. EDAT- 2017/10/24 06:00 MHDA- 2018/07/10 06:00 PMCR- 2017/11/01 CRDT- 2017/10/24 06:00 PHST- 2017/09/08 00:00 [received] PHST- 2017/10/14 00:00 [accepted] PHST- 2017/10/24 06:00 [pubmed] PHST- 2018/07/10 06:00 [medline] PHST- 2017/10/24 06:00 [entrez] PHST- 2017/11/01 00:00 [pmc-release] AID - kjim.2017.314 [pii] AID - kjim-2017-314 [pii] AID - 10.3904/kjim.2017.314 [doi] PST - ppublish SO - Korean J Intern Med. 2017 Nov;32(6):967-973. doi: 10.3904/kjim.2017.314. Epub 2017 Oct 23.